Evidence map›Paper›PMID 29182308›Full record

ArticleAnalytical chemistry2018

Targeted MultiNotch MS

Bingming Chen, Xuefei Zhong, Yu Feng, Sergei Snovida, Meng Xu, John Rogers, Lingjun Li

Abstract read
In one paragraph

Article in Analytical chemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Review
  3. Analytical and bioanalytical chemistry · 2024
    Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Bingming Chen
Xuefei Zhong
Yu Feng
Sergei SnovidaThermo Fisher Scientific , Rockford, Illinois 61101, United States.
Meng Xu
John RogersThermo Fisher Scientific , Rockford, Illinois 61101, United States.
Thermo Fisher Scientific (United States) · US

Funding

TR&D 2 Metabolic Labels for Ultraplexed Protein Quantification p. 453P41GM108538 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI COON, JOSHUA J · 2016 to 2025
$13.1M
Mass Spectrometric Studies of Neuropeptides in FeedingR01DK071801 · NIDDK · UNIVERSITY OF WISCONSIN-MADISON · PI LINGJUN LI · 2006 to 2026
$6.7M
Acquisition of a High-Field Dual Source FTICR-MS for Pharmaceutical ResearchS10RR029531 · NCRR · UNIVERSITY OF WISCONSIN-MADISON · PI LI, LINGJUN · 2011 to 2011
$2.1M
Mass Defect-based Chemical Tags for Multiplex Glycan QuantitationR21AG055377 · NIA · UNIVERSITY OF WISCONSIN-MADISON · PI LI, LINGJUN · 2016 to 2017
$603k
NCRR NIH HHS S10 RR029531NIA NIH HHS R21 AG055377NIDDK NIH HHS R01 DK071801NIGMS NIH HHS P41 GM108538
6 · The paper itself

Abstract

The recently developed and commercially available carbonyl-reactive tandem mass tags (aminoxyTMT) enable multiplexed quantification of glycans through comparison of reporter ion intensities. However, challenges still exist for collision activated dissociation (CAD) MS/MS based quantification of aminoxyTMT due to the relatively low reporter ion yield especially for glycans with labile structures. To circumvent this limitation, we utilized the unique structural features of N-glycan molecules, the common core sugar sequence (HexNAc)

Indexed as

Blood ProteinsChromatography, LiquidGlycoproteinsHumansIndicators and ReagentsPolysaccharidesProteomicsTandem Mass SpectrometryBlood ProteinsGlycoproteinsIndicators and ReagentsPolysaccharides

Identifiers

PMID29182308
PMCPMC5899513
OpenAlexW2769300889

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.